Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Pfizer, inc. symbols : AMGN save search
Rapid Adoption of Epinephrine Autoinjectors Among Individuals Spurs Market Growth at a CAGR of 9.56% till 2027
Published: 2023-09-11 (Crawled : 16:00) - prnewswire.com
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: -0.03%
H: 0.18%
C: -0.88%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: 2.42%
H: 0.0%
C: 0.0%
BDX | $234.61 0.63% 120K
|
Health Technology
|
| O: 0.18%
H: 0.52%
C: -0.02%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: 1.65%
H: 0.0%
C: 0.0%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: -0.47%
H: 1.78%
C: 1.36%
rapid epinephrine growth market
Biosimilars Market worth $66.9 billion | MarketsandMarkets
Published: 2023-06-15 (Crawled : 10:00) - prnewswire.com
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.13%
H: 1.07%
C: 0.86%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 1.04%
H: 0.78%
C: 0.67%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: 0.06%
H: 1.91%
C: 1.32%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: 0.33%
H: 2.62%
C: 2.43%
market
Regenerative Medicine Market to be Worth $180.87 Billion by 2030: Grand View Research, Inc.
Published: 2023-02-14 (Crawled : 10:00) - prnewswire.com
AZNCF | $138.24 -1.36% 0
|
Health Technology
|
| O: 0.43%
H: 1.52%
C: -1.88%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
USRM | $0.0001 1300.0% 290K
|
Professional, Scientific, and T...
|
| O: 2.22%
H: 4.35%
C: 4.35%
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.23%
H: 0.25%
C: -0.84%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.27%
H: 0.42%
C: -0.21%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: 0.04%
H: 0.93%
C: -0.85%
NUVA | $39.75 -2.24% -2.29% 0
|
Health Technology
|
| O: -0.16%
H: 2.24%
C: 0.79%
MDXG | $6.155 -0.08% 46K
|
Health Technology
|
| O: -1.3%
H: 2.85%
C: 2.19%
AZN | $68.505 0.21% 580K
|
Health Technology
|
| O: 0.3%
H: 0.94%
C: 0.6%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: -0.39%
H: 0.12%
C: -0.69%
market
Global Axial Spondyloarthritis Market Research Repoirt 2022: Biopharmaceutical Companies are Trying to Match Themselves with New Technologies in the Market to Improve the Overall System
Published: 2022-06-14 (Crawled : 11:00) - prnewswire.com
UCBJY | $63.676 7.2K
|
Manufacturing
|
| O: -0.22%
H: 0.0%
C: -1.02%
TAK | News | $13.235 0.57% 100K
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: -2.24%
H: 0.0%
C: 0.0%
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: -0.4%
H: 0.33%
C: -0.91%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: -1.04%
H: 0.87%
C: -1.31%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: -0.41%
H: 0.73%
C: -0.54%
research system companies market
Global Anti-Osteoporosis Therapy & Fracture Healing Market to 2027 - Featuring Actavis, Amgen and DJO Global Among Others
Published: 2022-04-04 (Crawled : 11:00) - prnewswire.com
GLAXF | $20.2 0.65% 0
|
Health Technology
|
| O: -3.27%
H: 0.0%
C: -3.52%
ZBH | $119.66 0.28% 140K
|
Health Technology
|
| O: -0.63%
H: 0.27%
C: -0.84%
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.41%
H: 0.17%
C: -1.62%
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
GSK | $39.565 0.75% 170K
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: 0.03%
H: 0.76%
C: -0.45%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: -0.12%
H: 1.49%
C: 0.84%
therapy market
Regenerative Medicine Market Size Worth $57.08 Billion By 2027: Grand View Research, Inc.
Published: 2021-08-12 (Crawled : 09:00) - prnewswire.com
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.41%
H: 1.94%
C: 1.59%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.28%
H: 0.36%
C: 0.13%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: -0.34%
H: 0.51%
C: 0.1%
NUVA | $39.75 -2.24% -2.29% 0
|
Health Technology
|
| O: -0.28%
H: 1.38%
C: 0.05%
MDXG | $6.155 -0.08% 46K
|
Health Technology
|
| O: -0.51%
H: 6.92%
C: 6.63%
AZN | $68.505 0.21% 580K
|
Health Technology
|
| O: 0.79%
H: 0.84%
C: 0.7%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: 0.03%
H: 0.56%
C: -0.02%
research
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-07-23 (Crawled : 00:00) - fda.gov
XERS | $1.755 -0.28% 160K
|
Health Technology
| Email alert
Add to watchlist
BCRX | $4.535 0.78% 270K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.135 1.64% 270K
|
Health Technology
| Email alert
Add to watchlist
PFE A | $25.44 0.2% 4.4M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $263.65 0.34% 360K
|
Health Technology
| Email alert
Add to watchlist
GILD | News | $66.52 0.54% 780K
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.295 -0.01% 920K
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $165.09 0.26% 760K
|
Health Technology
| Email alert
Add to watchlist
LLY | $745.04 -0.12% 410K
|
Health Technology
| Email alert
Add to watchlist
OMER | $3.205 -0.16% 40K
|
Health Technology
| Email alert
Add to watchlist
SCYX | $1.41 0.36% 8.2K
|
Health Technology
| Email alert
Add to watchlist
OTIC | $0.077
|
Health Technology
| Email alert
Add to watchlist
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-24 (Crawled : 14:03) - fda.gov
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.23%
H: 0.52%
C: 0.13%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: 8.21%
H: 1.89%
C: -0.83%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: 0.31%
H: 1.15%
C: 0.6%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: 0.37%
H: 1.55%
C: 0.28%
XERS | $1.755 -0.28% 160K
|
Health Technology
|
| O: 0.0%
H: 10.77%
C: 10.77%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: 0.29%
H: 0.8%
C: 0.17%
OTIC | $0.077
|
Health Technology
|
| O: -0.89%
H: 3.14%
C: 1.35%
OMER | $3.205 -0.16% 40K
|
Health Technology
|
| O: 0.32%
H: 0.87%
C: 0.26%
GILD | News | $66.52 0.54% 780K
|
Health Technology
|
| O: 0.18%
H: 2.2%
C: 0.61%
BCRX | $4.535 0.78% 270K
|
Health Technology
|
| O: 0.06%
H: 0.35%
C: 0.0%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: 0.71%
H: 1.09%
C: 0.22%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-21 (Crawled : 00:00) - fda.gov
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.18%
H: 1.54%
C: 1.39%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: 0.25%
H: 2.13%
C: 1.63%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: 0.21%
H: 0.83%
C: 0.33%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: 0.5%
H: 1.37%
C: 0.91%
XERS | $1.755 -0.28% 160K
|
Health Technology
|
| O: 0.24%
H: 0.73%
C: -4.13%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: -0.32%
H: 0.17%
C: -0.13%
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 3.98%
C: -1.33%
OMER | $3.205 -0.16% 40K
|
Health Technology
|
| O: 1.39%
H: 0.79%
C: 0.33%
GILD | News | $66.52 0.54% 780K
|
Health Technology
|
| O: 0.57%
H: 0.86%
C: 0.54%
BCRX | $4.535 0.78% 270K
|
Health Technology
|
| O: 0.5%
H: 4.88%
C: 4.7%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: 0.4%
H: 0.53%
C: 0.25%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-09 (Crawled : 10:51) - fda.gov
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.39%
H: 2.15%
C: 2.08%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: 0.29%
H: 2.43%
C: 2.1%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: 0.5%
H: 2.39%
C: 2.16%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: 0.48%
H: 1.36%
C: 0.99%
XERS | $1.755 -0.28% 160K
|
Health Technology
|
| O: 7.18%
H: 4.52%
C: -4.07%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: 0.88%
H: 0.74%
C: 0.5%
OTIC | $0.077
|
Health Technology
|
| O: -0.84%
H: 5.93%
C: 0.42%
OMER | $3.205 -0.16% 40K
|
Health Technology
|
| O: 0.95%
H: 2.0%
C: 0.25%
GILD | News | $66.52 0.54% 780K
|
Health Technology
|
| O: 0.09%
H: 2.4%
C: 1.6%
BCRX | $4.535 0.78% 270K
|
Health Technology
|
| O: 0.82%
H: 2.39%
C: -1.11%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: 0.46%
H: 1.42%
C: 0.67%
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-28 (Crawled : 18:31) - fda.gov
ALNY | News | $146.2 0.72% 39K
|
Health Technology
| Email alert
Add to watchlist
REGN | $901.745 0.87% 87K
|
Health Technology
| Email alert
Add to watchlist
INCY | $52.755 -0.12% 150K
|
Health Technology
| Email alert
Add to watchlist
VSTM | $10.135 -0.93% 4.4K
|
Health Technology
| Email alert
Add to watchlist
EXEL | $22.46 -0.13% 320K
|
Health Technology
| Email alert
Add to watchlist
YMAB | $15.33 2.2% 42K
|
Health Technology
| Email alert
Add to watchlist
KPTI | $1.275 -0.39% 350K
|
Health Technology
| Email alert
Add to watchlist
LLY | $745.04 -0.12% 410K
|
Health Technology
| Email alert
Add to watchlist
BGNE | $129.675 -1.73% 45K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $117.97 1.1% 160K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $263.65 0.34% 360K
|
Health Technology
| Email alert
Add to watchlist
PFE A | $25.44 0.2% 4.4M
|
Health Technology
| Email alert
Add to watchlist
BPMC | News | $89.55 0.73% 55K
|
Health Technology
| Email alert
Add to watchlist
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.295 -0.01% 920K
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.88 2.52% 42K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.135 1.64% 270K
|
Health Technology
| Email alert
Add to watchlist
RIGL | $1.075 2.38% 120K
|
Health Technology
| Email alert
Add to watchlist
AGIO | News | $30.24 2.75% 180K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $165.09 0.26% 760K
|
Health Technology
| Email alert
Add to watchlist
cancer approval
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-05-24 (Crawled : 00:00) - fda.gov
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.33%
H: 0.15%
C: -0.67%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: 0.56%
H: 1.3%
C: 0.01%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: 0.33%
H: 1.03%
C: 0.03%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: 0.4%
H: 0.19%
C: -0.58%
XERS | $1.755 -0.28% 160K
|
Health Technology
|
| O: -1.15%
H: 1.46%
C: -4.66%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: 0.02%
H: 0.3%
C: -0.3%
REGN | $901.745 0.87% 87K
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: -1.82%
OTIC | $0.077
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: -7.2%
OMER | $3.205 -0.16% 40K
|
Health Technology
|
| O: 0.94%
H: 1.4%
C: 1.06%
GILD | News | $66.52 0.54% 780K
|
Health Technology
|
| O: 0.51%
H: 0.2%
C: -2.42%
BCRX | $4.535 0.78% 270K
|
Health Technology
|
| O: 0.43%
H: 1.44%
C: -2.16%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: -0.18%
H: 1.17%
C: -1.12%
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-21 (Crawled : 18:33) - fda.gov
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.22%
H: 0.97%
C: -0.65%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
ADCT | $4.88 2.52% 42K
|
Health Technology
|
| O: 2.54%
H: 0.48%
C: -0.29%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: 0.35%
H: 0.65%
C: -1.19%
YMAB | $15.33 2.2% 42K
|
Health Technology
|
| O: 0.58%
H: 1.24%
C: -1.66%
VSTM | $10.135 -0.93% 4.4K
|
Health Technology
|
| O: 0.63%
H: 2.49%
C: -0.62%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
RIGL | $1.075 2.38% 120K
|
Health Technology
|
| O: 0.82%
H: 1.08%
C: -1.62%
REGN | $901.745 0.87% 87K
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: -1.44%
KPTI | $1.275 -0.39% 350K
|
Health Technology
|
| O: 0.31%
H: 1.15%
C: -1.46%
INCY | $52.755 -0.12% 150K
|
Health Technology
|
| O: 0.57%
H: 0.6%
C: -1.46%
ILMN | $117.97 1.1% 160K
|
Health Technology
|
| O: 0.33%
H: 2.2%
C: 0.21%
EXEL | $22.46 -0.13% 320K
|
Health Technology
|
| O: 0.08%
H: 1.64%
C: 0.45%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: -2.62%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.95%
H: 1.31%
C: -2.81%
BPMC | News | $89.55 0.73% 55K
|
Health Technology
|
| O: 1.12%
H: 0.84%
C: -0.08%
BGNE | $129.675 -1.73% 45K
|
Health Technology
|
| O: 0.1%
H: 1.6%
C: 0.88%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.19%
H: 1.71%
C: -0.33%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: 0.71%
H: 0.14%
C: -1.06%
ALNY | News | $146.2 0.72% 39K
|
Health Technology
|
| O: 0.38%
H: 1.01%
C: -0.41%
AGIO | News | $30.24 2.75% 180K
|
Health Technology
|
| O: 0.86%
H: 1.27%
C: -0.24%
cancer approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-20 (Crawled : 18:26) - fda.gov
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.22%
H: 0.97%
C: -0.65%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
ADCT | $4.88 2.52% 42K
|
Health Technology
|
| O: 2.54%
H: 0.48%
C: -0.29%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: 0.35%
H: 0.65%
C: -1.19%
YMAB | $15.33 2.2% 42K
|
Health Technology
|
| O: 0.58%
H: 1.24%
C: -1.66%
VSTM | $10.135 -0.93% 4.4K
|
Health Technology
|
| O: 0.63%
H: 2.49%
C: -0.62%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
RIGL | $1.075 2.38% 120K
|
Health Technology
|
| O: 0.82%
H: 1.08%
C: -1.62%
REGN | $901.745 0.87% 87K
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: -1.44%
KPTI | $1.275 -0.39% 350K
|
Health Technology
|
| O: 0.31%
H: 1.15%
C: -1.46%
INCY | $52.755 -0.12% 150K
|
Health Technology
|
| O: 0.57%
H: 0.6%
C: -1.46%
ILMN | $117.97 1.1% 160K
|
Health Technology
|
| O: 0.33%
H: 2.2%
C: 0.21%
EXEL | $22.46 -0.13% 320K
|
Health Technology
|
| O: 0.08%
H: 1.64%
C: 0.45%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: -2.62%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.95%
H: 1.31%
C: -2.81%
BPMC | News | $89.55 0.73% 55K
|
Health Technology
|
| O: 1.12%
H: 0.84%
C: -0.08%
BGNE | $129.675 -1.73% 45K
|
Health Technology
|
| O: 0.1%
H: 1.6%
C: 0.88%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.19%
H: 1.71%
C: -0.33%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: 0.71%
H: 0.14%
C: -1.06%
ALNY | News | $146.2 0.72% 39K
|
Health Technology
|
| O: 0.38%
H: 1.01%
C: -0.41%
AGIO | News | $30.24 2.75% 180K
|
Health Technology
|
| O: 0.86%
H: 1.27%
C: -0.24%
cancer approval
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-05-18 (Crawled : 13:27) - fda.gov
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.17%
H: 0.41%
C: -0.32%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: -0.27%
H: 0.69%
C: -0.19%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: -0.06%
H: 0.58%
C: 0.28%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: -0.67%
H: 1.54%
C: 0.95%
XERS | $1.755 -0.28% 160K
|
Health Technology
|
| O: 0.0%
H: 5.46%
C: 3.16%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: 0.22%
H: 0.1%
C: -0.26%
REGN | $901.745 0.87% 87K
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: -1.3%
OTIC | $0.077
|
Health Technology
|
| O: -0.84%
H: 4.63%
C: 1.7%
OMER | $3.205 -0.16% 40K
|
Health Technology
|
| O: 0.06%
H: 1.35%
C: -0.06%
GILD | News | $66.52 0.54% 780K
|
Health Technology
|
| O: 0.49%
H: 0.66%
C: -0.81%
BCRX | $4.535 0.78% 270K
|
Health Technology
|
| O: -0.76%
H: 4.91%
C: 0.77%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: -0.12%
H: 0.4%
C: -0.48%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-05-12 (Crawled : 17:43) - fda.gov
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.23%
H: 1.22%
C: 0.63%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: 0.0%
H: 0.46%
C: -0.8%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: 0.26%
H: 1.24%
C: 0.16%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: -0.03%
H: 1.0%
C: 0.1%
XERS | $1.755 -0.28% 160K
|
Health Technology
|
| O: -2.68%
H: 7.56%
C: 0.05%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: -0.46%
H: 0.95%
C: 0.12%
REGN | $901.745 0.87% 87K
|
Health Technology
|
| O: -0.84%
H: 3.35%
C: 2.04%
OTIC | $0.077
|
Health Technology
|
| O: 1.92%
H: 4.25%
C: 1.42%
OMER | $3.205 -0.16% 40K
|
Health Technology
|
| O: -1.41%
H: 2.86%
C: -1.76%
GILD | News | $66.52 0.54% 780K
|
Health Technology
|
| O: -0.7%
H: 1.8%
C: 1.05%
BCRX | $4.535 0.78% 270K
|
Health Technology
|
| O: -1.98%
H: 6.47%
C: 4.96%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: -0.35%
H: 0.92%
C: -0.23%
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-05 (Crawled : 18:31) - fda.gov
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: -3.73%
H: 1.95%
C: 1.85%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: -0.65%
H: 1.33%
C: 1.22%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: -0.12%
H: 0.19%
C: -0.22%
ADCT | $4.88 2.52% 42K
|
Health Technology
|
| O: 3.45%
H: 1.01%
C: -0.66%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: -0.67%
H: 1.03%
C: 0.94%
YMAB | $15.33 2.2% 42K
|
Health Technology
|
| O: -0.85%
H: 2.64%
C: 2.1%
VSTM | $10.135 -0.93% 4.4K
|
Health Technology
|
| O: -2.03%
H: 0.82%
C: -1.72%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: 0.55%
H: 0.51%
C: 0.29%
RIGL | $1.075 2.38% 120K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -6.05%
REGN | $901.745 0.87% 87K
|
Health Technology
|
| O: 0.14%
H: 4.11%
C: 3.22%
KPTI | $1.275 -0.39% 350K
|
Health Technology
|
| O: 0.37%
H: 1.11%
C: 0.0%
INCY | $52.755 -0.12% 150K
|
Health Technology
|
| O: -0.09%
H: 1.99%
C: 1.35%
ILMN | $117.97 1.1% 160K
|
Health Technology
|
| O: -0.64%
H: 0.34%
C: 0.31%
EXEL | $22.46 -0.13% 320K
|
Health Technology
|
| O: -0.88%
H: 0.34%
C: -2.27%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: -9.2%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: -0.34%
H: 0.86%
C: -2.91%
BPMC | News | $89.55 0.73% 55K
|
Health Technology
|
| O: -0.26%
H: 2.88%
C: 2.72%
BGNE | $129.675 -1.73% 45K
|
Health Technology
|
| O: 0.14%
H: 3.67%
C: 2.67%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.3%
H: 0.15%
C: -1.78%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: -0.03%
H: 0.88%
C: 0.81%
ALNY | News | $146.2 0.72% 39K
|
Health Technology
|
| O: -0.51%
H: 1.52%
C: 0.08%
AGIO | News | $30.24 2.75% 180K
|
Health Technology
|
| O: -0.45%
H: 4.45%
C: 3.9%
cancer approval
A Growing Market For Rare Disease Treatments Opens Up New Opportunities
Published: 2021-04-28 (Crawled : 13:00) - prnewswire.com
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.23%
H: 1.04%
C: 0.7%
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -0.2%
H: 0.21%
C: -0.54%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: 0.21%
H: 0.43%
C: -0.11%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: -5.33%
H: 1.01%
C: -1.99%
disease treatment growing rare
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-23 (Crawled : 18:42) - fda.gov
LLY | $745.04 -0.12% 410K
|
Health Technology
| Email alert
Add to watchlist
RIGL | $1.075 2.38% 120K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $117.97 1.1% 160K
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.295 -0.01% 920K
|
Health Technology
| Email alert
Add to watchlist
BGNE | $129.675 -1.73% 45K
|
Health Technology
| Email alert
Add to watchlist
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
KPTI | $1.275 -0.39% 350K
|
Health Technology
| Email alert
Add to watchlist
ALNY | News | $146.2 0.72% 39K
|
Health Technology
| Email alert
Add to watchlist
PFE A | $25.44 0.2% 4.4M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $165.09 0.26% 760K
|
Health Technology
| Email alert
Add to watchlist
AGIO | News | $30.24 2.75% 180K
|
Health Technology
| Email alert
Add to watchlist
VSTM | $10.135 -0.93% 4.4K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
REGN | $901.745 0.87% 87K
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
YMAB | $15.33 2.2% 42K
|
Health Technology
| Email alert
Add to watchlist
BPMC | News | $89.55 0.73% 55K
|
Health Technology
| Email alert
Add to watchlist
EXEL | $22.46 -0.13% 320K
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.88 2.52% 42K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.135 1.64% 270K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $263.65 0.34% 360K
|
Health Technology
| Email alert
Add to watchlist
INCY | $52.755 -0.12% 150K
|
Health Technology
| Email alert
Add to watchlist
cancer approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-22 (Crawled : 17:37) - fda.gov
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: -0.13%
H: 0.05%
C: -2.13%
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: -0.5%
H: 0.67%
C: -1.55%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: -0.26%
H: 0.62%
C: 0.26%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: -0.14%
H: 0.4%
C: -0.54%
YMAB | $15.33 2.2% 42K
|
Health Technology
|
| O: 0.37%
H: 4.78%
C: 0.9%
VSTM | $10.135 -0.93% 4.4K
|
Health Technology
|
| O: 0.35%
H: 4.42%
C: -0.35%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: -0.93%
H: 0.27%
C: 0.17%
RIGL | $1.075 2.38% 120K
|
Health Technology
|
| O: -0.27%
H: 2.99%
C: -0.54%
REGN | $901.745 0.87% 87K
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: -2.96%
KPTI | $1.275 -0.39% 350K
|
Health Technology
|
| O: 0.42%
H: 2.7%
C: -0.1%
INCY | $52.755 -0.12% 150K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: -0.38%
ILMN | $117.97 1.1% 160K
|
Health Technology
|
| O: -0.32%
H: 2.34%
C: 1.59%
EXEL | $22.46 -0.13% 320K
|
Health Technology
|
| O: -0.61%
H: 1.63%
C: 0.57%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 0.51%
H: 1.39%
C: -0.38%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.63%
H: 4.67%
C: 0.86%
BPMC | News | $89.55 0.73% 55K
|
Health Technology
|
| O: 0.27%
H: 1.3%
C: -0.8%
BGNE | $129.675 -1.73% 45K
|
Health Technology
|
| O: 0.0%
H: 3.94%
C: 3.0%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.15%
H: 3.9%
C: 1.2%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: -0.48%
H: 0.36%
C: -0.97%
ALNY | News | $146.2 0.72% 39K
|
Health Technology
|
| O: -0.79%
H: 2.9%
C: 0.97%
AGIO | News | $30.24 2.75% 180K
|
Health Technology
|
| O: 0.38%
H: 1.41%
C: -0.23%
cancer approval
Gainers vs Losers
| 84% | 16% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
ZCMD | $2.18 50.35% 24M
|
Commercial Services
CHRO | $1.73 41.22% 46K
|
n/a
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
PRTG | $0.285 18.75% 140K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.